切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2015, Vol. 11 ›› Issue (4) : 511 -515. doi: 10.3877/cma.j.issn.1673-5250.2015.04.016

所属专题: 文献

论著

儿童原发性肾病综合征尿足细胞标志蛋白、足细胞裂孔膜蛋白与尿蛋白关系的研究
苏敏*(), 才绍江, 李真真, 宁芳, 丁美娇   
  1. 150010 哈尔滨市儿童医院
  • 收稿日期:2015-02-03 修回日期:2015-06-12 出版日期:2015-08-01
  • 通信作者: 苏敏

The research relationship between urinary podocalyxin, nephrin and urinary protein in children with primary nephrotic syndrome

Min Su*(), Shaojiang Cai, Zhenzhen Li, Fang Ning, Meijiao Ding   

  1. Harbin Children's Hospital, Harbin 150010, Heilongjiang Province, China
  • Received:2015-02-03 Revised:2015-06-12 Published:2015-08-01
  • Corresponding author: Min Su
引用本文:

苏敏, 才绍江, 李真真, 宁芳, 丁美娇. 儿童原发性肾病综合征尿足细胞标志蛋白、足细胞裂孔膜蛋白与尿蛋白关系的研究[J]. 中华妇幼临床医学杂志(电子版), 2015, 11(4): 511-515.

Min Su, Shaojiang Cai, Zhenzhen Li, Fang Ning, Meijiao Ding. The research relationship between urinary podocalyxin, nephrin and urinary protein in children with primary nephrotic syndrome[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2015, 11(4): 511-515.

目的

探索儿童原发性肾病综合征(NS)蛋白尿与足突损伤间的关系。

方法

选择2013年9月至2014年3月于哈尔滨市儿童医院泌尿内科住院的20例原发性NS患儿为研究对象,并纳入肾病组(n=20)。选择同期于该院门诊体检的10例健康儿童为正常对照组(n=10)。研究组患儿均接受肾上腺糖皮质激素治疗。应用酶联免疫吸附试验(ELISA)方法检测肾病组患儿不同观察时刻及正常对照组儿童随机尿足细胞标志蛋白(PCX)、足细胞裂孔膜蛋白(nephrin)水平,采用免疫比浊法及比色法测定患儿尿蛋白及尿肌酐水平,并计算尿蛋白、尿肌酐比值。

结果

①肾病组患儿尿PCX、nephrin水平和尿蛋白、尿肌酐比值均显著高于正常对照组,且差异有统计学意义(t=2.612,2.843,2.972;P<0.01)。②肾病组患儿激素治疗期间尿PCX、nephrin水平和尿蛋白/尿肌酐比值总体均呈下降趋势。相邻观察时刻的尿PCX与nephrin水平比较,差异均无统计学意义(P>0.05)。治疗第8天尿PCX和nephrin水平较治疗前显著下降,且差异有统计学意义(t=1.934,2.093;P<0.05)。治疗第6天尿蛋白、尿肌酐比值较第4天和治疗前显著下降,且差异也有统计学意义(t=2.042,2.120;P<0.05)。③尿PCX、nephrin水平分别与尿蛋白、尿肌酐比值呈正相关关系(r=0.91,0.92;P<0.01)。

结论

尿PCX、nephrin水平随NS的恢复而逐渐下降,与尿蛋白指标有良好的相关性,对其进行监测可动态观察足细胞变化,对判断肾小球的损伤及恢复情况有一定的临床意义。

Objective

To identify the relationships between proteinuria and foot process damage of primary nephrotic syndrome(NS).

Methods

From September 2013 to March 2014, a total of 20 patients with primary NS were selected as the research group(n=20) in Harbin Children's Hospital.Meanwhile 10 healthy children were selected as normal control group(n=10). The children in research group were treated with adrenal cortex hormone therapy.The levels of podocalyxin (PCX) and nephrin at different observation time in the nephropathy group and at random interval in normal control group were detected by enzyme-linked immunosorbent assay (ELISA) method.The serum levels of urine protein and urine creatinine were measured by the method of turbidimetric inhibition immuno assay and colorimetry.

Results

①The levels of urinary PCX, nephrin and urine protein/creatinine in research group were significantly higher than those of the normal control group(t=2.612, 2.843, 2.972; P<0.01). ②PCX, nephrin and urine protein/urine creatinine levels were decreased during the treatment in research group. There was no significant difference in urine PCX and nephrin between every couple of adjacent observation time (P>0.05). The levels of urinary PCX and nephrin were significantly decreased between the eighth day and before treatment, and the differences were statistically significant(t=1.934, 2.093; P<0.05). The levels of urinary protein/urine creatinine were significantly decreased between the sixth day and the forth day or before treatment, and the differences were also statistically significant(t=2.042, 2.120; P<0.05). ③PCX and nephrin levels were positively correlated with urine protein/urine creatinine levels (r=0.91, 0.92; P<0.01).

Conclusions

The levels of PCX and nephrin decreased with the recovery of NS, and it had a good correlation with urinary protein index, carrying on a quantitative detection of dynamic observation podocyte changes.It has certain clinical significance for judging the glomerular damage and recovery.

表1 两组儿童尿PCX、nephrin水平及尿蛋白、尿肌酐比值比较(±s)
表2 儿童肾病恢复期尿PCX、nephrin水平及尿蛋白、尿肌酐比值比较(±s)
图1 儿童肾病不同观察时刻尿PCX、nephrin水平和尿蛋白/尿肌酐比值比较
图2 尿PCX与尿蛋白/尿肌酐直线相关分析
图3 尿nephrin与尿蛋白/尿肌酐直线相关分析
[1]
中华医学会儿科学分会肾脏病学组.小儿肾小球疾病的临床分类、诊断及治疗[J].中华儿科杂志2001;39(12):746–749.
[2]
Asao R, Asanuma K, Kodama F,et al. Relationships between levels of urinary podocalyxin,number of urinary podocalyxin,number of urinary podocytes,and histologic injury in adult patients with IgA nephropathy[J].Clin J Am Soc Nephrol20127(9):1385–1393.
[3]
Zhu BLi XFZhu XL,et al. ELISA analysis of urinary nephrin and podocalyxin standardized by aquaporin-2 in adult patients with nephritic syndrome[J].J Nephrol201427(4):411–417.
[4]
Mundel PShankland SJ.Podocyte biology and response to injury[J].J Am Soc Nephrol200213(12):3005–3015.
[5]
邢燕,叶山东.Podocalyxin与糖尿病肾病的关系[J].国际病理科学与临床杂志201131(2):172–174.
[6]
Kanno KKawachi HUchida Y,et al.Urinary sediment podocalyxin in children with glomerular disease[J].Nephron Clin Pract200395(3):91–99.
[7]
Habara PMareckova HMalickova K,et al.Novel flow cytometric method for the detection of podocalyxin-positive elements in urine of pations with glomerulinephritide-first promising results[J].Folia Biol(Praha)201258(2):57–63.
[8]
邢燕,丁洁,范青锋.足细胞分子高表达致阿霉素肾病大鼠发生蛋白尿[J].中华肾脏病杂志200622(1):281–285.
[9]
邓江红,丁洁.从足细胞相关分子的研究认识足突融合现象[J].肾脏病与透析移植20054(14):354–356.
[10]
张焱,黄建萍,肖慧捷,等.甲基泼尼松龙冲击疗法治疗小儿肾病综合征复发疗效观察[J].临床儿科杂志200725(4):274–277.
[11]
刘涛,张碧丽,李莉.检测原发性肾病综合征患儿尿足细胞标志蛋白的临床意义[J].中国当代儿科杂志201214(5):332–335.
[12]
刘海梅,徐虹,高霞.地塞米松影响足细胞活动力的相关分子研究[J].中华肾脏病杂志20129(28):705–709.
[13]
赵向娅,冯晓蓓,王朝晖.尿足细胞及其相关分子在肾小球疾病中的表达[J]. 中国中西医结合肾病杂志20096(6):489–493.
[14]
鲁艳芳,袁军.足细胞相关分子与蛋白尿的关系[J].中国中西医结合儿科学20091(1):74–77.
[15]
张爱华.肾小球足细胞裂孔隔膜分子在蛋白尿发生中的作用[J].医学研究生学报20097(22):673–676.
[1] 李志娟, 包瑛, 黄惠梅, 杨楠, 张敏, 王莹, 骞佩, 牛云鹤. A20单倍剂量不足合并系统性红斑狼疮1例并文献复习[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(03): 315-322.
[2] 智元昭, 曹璐, 窦文杰, 王琴, 张建江. 利妥昔单抗治疗儿童非复杂性激素依赖型肾病综合征疗效分析[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(01): 54-60.
[3] 张潇尹, 于洋. 牙龈卟啉单胞菌介导慢性肾病发生发展的研究进展[J]. 中华口腔医学研究杂志(电子版), 2023, 17(05): 328-334.
[4] 代叶梅, 苏晓乐, 王利华. 膜性肾病靶抗原的研究进展[J]. 中华肾病研究电子杂志, 2023, 12(05): 282-286.
[5] 杨蕴钊, 周诚, 石美涵, 赵静, 白雪源. 人羊水间充质干细胞对膜性肾病大鼠的治疗作用[J]. 中华肾病研究电子杂志, 2023, 12(04): 181-186.
[6] 程莉, 章晓良. 血尿酸和胱抑素C与糖尿病视网膜病变患者合并糖尿病肾病的关系及影响因素[J]. 中华肾病研究电子杂志, 2023, 12(04): 194-199.
[7] 吴琼, 朱国贞. 膜性肾病中M2巨噬细胞相关基因的生物信息学分析[J]. 中华肾病研究电子杂志, 2023, 12(03): 156-162.
[8] 邓荣珍, 罗宇珍, 赵若蓓, 邓杨, 廖蕴华, 潘玲. 血脂与IgA肾病患者肾脏预后的相关性研究[J]. 中华肾病研究电子杂志, 2023, 12(01): 13-19.
[9] 王素霞. 非典型膜性肾病的病理表现和鉴别诊断思路[J]. 中华肾病研究电子杂志, 2022, 11(06): 360-360.
[10] 吴萌, 吴国仲, 王贵红, 端靓靓, 施杰, 王旭, 余婷, 刘伟. IgA肾病患者中性粒细胞-淋巴细胞比值与肾小管萎缩/间质纤维化相关性分析[J]. 中华临床医师杂志(电子版), 2023, 17(9): 972-979.
[11] 徐玲玲, 田汉, 闻萍, 何伟春. 利妥昔单抗治疗难治性微小病变性肾病一例并文献复习[J]. 中华临床医师杂志(电子版), 2023, 17(05): 617-621.
[12] 张赟辉, 罗军, 刘栗丽, 汪宏, 耿克明. 腹膜透析与血液透析对老年终末期肾病患者营养状况及炎症反应的影响[J]. 中华临床医师杂志(电子版), 2023, 17(04): 419-423.
[13] 朱艺平, 陈一平, 赵艳英, 陆玮玮, 牙侯军, 苏复霞. 二十味沉香丸调控糖尿病肾病大鼠肠道菌群益生菌构成的机制研究[J]. 中华临床医师杂志(电子版), 2022, 16(06): 572-578.
[14] 刘倩影, 刘雪彦, 周佩如, 胡申玲, 叶倩呈, 黄洁微. 糖尿病肾病患者血液透析期间低血糖管理的证据总结[J]. 中华肥胖与代谢病电子杂志, 2023, 09(01): 22-27.
[15] 白明悦, 杨淑娜, 胡红梅, 胡文立. 透析患者脑小血管病患病情况的研究现状及其机制探讨[J]. 中华脑血管病杂志(电子版), 2023, 17(05): 505-509.
阅读次数
全文


摘要